| Product NDC: | 25021-108 | 
| Proprietary Name: | Ceftriaxone | 
| Non Proprietary Name: | CEFTRIAXONE Sodium | 
| Active Ingredient(s): | 10 g/100mL & nbsp; CEFTRIAXONE Sodium | 
| Administration Route(s): | INTRAVENOUS | 
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 25021-108 | 
| Labeler Name: | Sagent Pharmaceuticals | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA065328 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20091105 | 
| Package NDC: | 25021-108-99 | 
| Package Description: | 1 BOTTLE in 1 CARTON (25021-108-99) > 100 mL in 1 BOTTLE | 
| NDC Code | 25021-108-99 | 
| Proprietary Name | Ceftriaxone | 
| Package Description | 1 BOTTLE in 1 CARTON (25021-108-99) > 100 mL in 1 BOTTLE | 
| Product NDC | 25021-108 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | CEFTRIAXONE Sodium | 
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION | 
| Route Name | INTRAVENOUS | 
| Start Marketing Date | 20091105 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Sagent Pharmaceuticals | 
| Substance Name | CEFTRIAXONE SODIUM | 
| Strength Number | 10 | 
| Strength Unit | g/100mL | 
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |